title: [Effectivity and satisfaction with the treatment for dyslipidemia with pitavastatin. Multicentric, descriptive, post authorised and observational study (REINA study)].
abstract: BACKGROUND
  Evaluating the therapeutical adherence as well as the patient' satisfaction with the treatment should be considered to optimize lipidic control. The REINA Study evaluates the grade of satisfaction in dyslipidemic patients treated with pitavastatin.
  
  
  METHODS
  The current study was observational, descriptive, transversal and multi-centric with patients from our country only. The following data were collected in each case: Morisky-Green test and TSQM-9 for patients older than 18 years old, with dyslipidemia treated with pitavastatin in the last 12 weeks.
  
  
  RESULTS
  We studied 6,489 patients (60.0% males) from Primary Health (52.7%) and Specialised Health (47.3%), with age (mean) = 60.9 ± 11.2 years by aleatory sampling. 72.3% of patients achieved an adequate control with 2mg/day of pitavastatin. General satisfaction with the treatment was 73.20 points (95% CI: 58.17-87.23). Patients who followed the treatment (65%) showed better data of satisfaction with the drug (77.70 [95% CI: 65.20-90.20]), of global satisfaction (75.00 [95% CI: 61.50-88.50]) and their satisfaction with the drug efficiency was higher (72.50 [95% CI: 57.70-87.30]) than in the patients who did not finish the treatment (72.70 [95% CI: 59.30-85.74]; 68.5 [95% CI: 53.20-83.80] and 67.80 [95% CI: 53.70-81.90], respectively), P < .0001, without any difference between the two primary care systems.
  
  
  CONCLUSIONS
  The validation of the satisfaction is a crucial indicator in the evaluation of the services offered in health. Patients with the highest grade of satisfaction present better therapeutical adherence, and such a relation is bidirectional. The individuals who are satisfied and who followed the treatment obtained better clinical results. Pitavastatin is an effective therapeutic alternative for patients with dyslipidemia.
authors.affiliation: Gerencia de Atención Primaria El Bierzo, Ponferrada, León, España. Electronic address: larodrigueza@saludcastillayleon.es.
authors.forename: Luis Alberto
authors.initials: LA
authors.lastname: Rodríguez Arroyo
authors.affiliation: Centro de Salud Bembibre, Bembibre, León, España.
authors.forename: Angel
authors.initials: A
authors.lastname: Díaz Rodríguez
authors.affiliation: Unidad Funcional de Riesgo Vascular, Servicio de Medicina Interna, Hospital Universitario de Bellvitge, Idibell. CIBERObn-ISCIII, Hospitalet de Llobregat, Barcelona, España.
authors.forename: Xavier
authors.initials: X
authors.lastname: Pintó Sala
authors.affiliation: Institut Clínic de Medicina i Dermatología (ICMiD), Hospital Clínico, Barcelona, España.
authors.forename: Antonio
authors.initials: A
authors.lastname: Coca Payeras
authors.affiliation: Departamento Médico e Innovación en Salud, ESTEVE, Barcelona, España.
authors.forename: Joan
authors.initials: J
authors.lastname: Rius Tarruella
mesh_terms: D000368:Aged; D003430:Cross-Sectional Studies; D050171:Dyslipidemias / Q000188:drug therapy*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D055118:Medication Adherence; D008875:Middle Aged; D017060:Patient Satisfaction; D011804:Quinolines / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011804:Quinolines; C108475:pitavastatin
keywords: Adherencia terapéutica; Pitavastatin; Pitavastatina; Satisfacción con el tratamiento; Satisfaction with the treatment; Therapeutic adherence; Tratamiento de dislipidemias; Treatment for dyslipidemia